PL3240777T3 - Inhibitory arginazy oraz ich zastosowania terapeutyczne - Google Patents

Inhibitory arginazy oraz ich zastosowania terapeutyczne

Info

Publication number
PL3240777T3
PL3240777T3 PL15823405T PL15823405T PL3240777T3 PL 3240777 T3 PL3240777 T3 PL 3240777T3 PL 15823405 T PL15823405 T PL 15823405T PL 15823405 T PL15823405 T PL 15823405T PL 3240777 T3 PL3240777 T3 PL 3240777T3
Authority
PL
Poland
Prior art keywords
therapeutic applications
arginase inhibitors
arginase
inhibitors
therapeutic
Prior art date
Application number
PL15823405T
Other languages
English (en)
Inventor
Roman Błaszczyk
Joanna Brzezińska
Adam A Gołębiowski
Jacek Olczak
Original Assignee
Oncoarendi Therapeutics Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncoarendi Therapeutics Sa filed Critical Oncoarendi Therapeutics Sa
Publication of PL3240777T3 publication Critical patent/PL3240777T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic System
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96—Sulfur atom
PL15823405T 2014-12-29 2015-12-22 Inhibitory arginazy oraz ich zastosowania terapeutyczne PL3240777T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201462097163P 2014-12-29 2014-12-29
PL410665A PL410665A1 (pl) 2014-12-29 2014-12-29 Inhibitory arginazy oraz ich zastosowania terapeutyczne
EP15823405.4A EP3240777B1 (en) 2014-12-29 2015-12-22 Arginase inhibitors and their therapeutic applications
PCT/PL2015/050073 WO2016108707A1 (en) 2014-12-29 2015-12-22 Arginase inhibitors and their therapeutic applications

Publications (1)

Publication Number Publication Date
PL3240777T3 true PL3240777T3 (pl) 2019-10-31

Family

ID=56234474

Family Applications (2)

Application Number Title Priority Date Filing Date
PL410665A PL410665A1 (pl) 2014-12-29 2014-12-29 Inhibitory arginazy oraz ich zastosowania terapeutyczne
PL15823405T PL3240777T3 (pl) 2014-12-29 2015-12-22 Inhibitory arginazy oraz ich zastosowania terapeutyczne

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL410665A PL410665A1 (pl) 2014-12-29 2014-12-29 Inhibitory arginazy oraz ich zastosowania terapeutyczne

Country Status (7)

Country Link
US (1) US10329310B2 (pl)
EP (1) EP3240777B1 (pl)
CN (1) CN107406464B (pl)
AU (1) AU2015372690A1 (pl)
CA (1) CA2973474A1 (pl)
PL (2) PL410665A1 (pl)
WO (1) WO2016108707A1 (pl)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11845767B2 (en) 2019-06-14 2023-12-19 Rijksuniversiteit Groningen Arginase inhibitors

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL417066A1 (pl) 2016-05-04 2017-11-06 Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością Inhibitory arginazy oraz ich zastosowania terapeutyczne
EP3774843B1 (en) 2018-03-29 2022-05-25 Molecure SA Dipeptide piperidine derivatives
EP3810615A4 (en) 2018-06-20 2022-03-30 Merck Sharp & Dohme Corp. ARGINASE INHIBITORS AND METHODS OF USE
WO2020092528A1 (en) 2018-10-31 2020-05-07 Gilead Sciences, Inc. Substituted 6-azabenzimidazole compounds having hpk1 inhibitory activity
US11203591B2 (en) 2018-10-31 2021-12-21 Gilead Sciences, Inc. Substituted 6-azabenzimidazole compounds
CA3120196A1 (en) * 2018-11-16 2020-05-22 Arcus Biosciences, Inc. Inhibitors of arg1 and/or arg2
CN113395996A (zh) * 2019-02-08 2021-09-14 阿斯利康(瑞典)有限公司 精氨酸酶抑制剂及其使用方法
EP3972695A1 (en) 2019-05-23 2022-03-30 Gilead Sciences, Inc. Substituted exo-methylene-oxindoles which are hpk1/map4k1 inhibitors
KR20220038105A (ko) * 2019-07-23 2022-03-25 아스트라제네카 아베 아르기나제 저해제 및 이의 사용 방법
TW202228720A (zh) 2020-12-22 2022-08-01 波蘭商昂科艾倫迪治療法股份公司 精胺酸酶抑制劑及其使用方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ241954A (en) 1991-03-15 1994-01-26 Amgen Inc Compositions of g-csf for pulmonary administration.
US5451569A (en) 1994-04-19 1995-09-19 Hong Kong University Of Science And Technology R & D Corporation Limited Pulmonary drug delivery system
EP1049660A1 (en) 1997-10-10 2000-11-08 The Trustees Of The University Of Pennsylvania Compositions and methods for inhibiting arginase activity
US20100056480A1 (en) 2006-11-21 2010-03-04 Rijks Univesiteit Groningen Use of arginase inhibitors in the treatment of asthma and allergic rhinitis
CA2749853C (en) * 2009-01-26 2018-08-21 Trustees Of The University Of Pennsylvania Arginase inhibitors and methods of use
NZ603364A (en) 2010-04-22 2015-06-26 Mars Inc Inhibitors of arginase and their therapeutic applications
EP3719024A1 (en) 2010-10-26 2020-10-07 Mars, Incorporated Arginase inhibitors as therapeutics
CN104857005B (zh) * 2010-12-31 2019-04-26 阿斯利康公司 精氨酸酶抑制剂及其使用方法
BR112014009415B1 (pt) 2011-10-19 2021-11-23 Mars, Incorporated Composição farmacêutica, composto inbidor de arginase e seus usos
WO2013158262A1 (en) 2012-04-18 2013-10-24 Mars, Incorporated Ring constrained analogs as arginase inhibitors

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11845767B2 (en) 2019-06-14 2023-12-19 Rijksuniversiteit Groningen Arginase inhibitors

Also Published As

Publication number Publication date
US10329310B2 (en) 2019-06-25
CA2973474A1 (en) 2016-07-07
AU2015372690A1 (en) 2017-07-27
CN107406464A8 (zh) 2018-01-12
WO2016108707A1 (en) 2016-07-07
US20180009830A1 (en) 2018-01-11
EP3240777B1 (en) 2019-07-24
CN107406464A (zh) 2017-11-28
EP3240777A1 (en) 2017-11-08
PL410665A1 (pl) 2016-07-04
CN107406464B (zh) 2019-03-19

Similar Documents

Publication Publication Date Title
IL269462B (en) mdm2 inhibitors and therapeutic methods using them
IL262387A (en) Arginase inhibitors and their treatment applications
IL250415B (en) Antibodies against pd-l and methods of using them
HK1243072A1 (zh) 布羅莫結構域抑制劑及其用途
HK1243073A1 (zh) 治療性化合物及其用途
HK1244000B (zh) 多環氨基甲酰吡啶酮化合物及其藥物用途
GB201605126D0 (en) Inhibitors and their uses
GB201403093D0 (en) Therapeutic compounds and their use
PL3240777T3 (pl) Inhibitory arginazy oraz ich zastosowania terapeutyczne
GB201404470D0 (en) Therapeutic methods and materials
IL255530A (en) Efflux-pump inhibitors and therapeutic uses thereof
EP3177327A4 (en) Inhibitors of myh7b and uses thereof
HK1243077A1 (zh) 呱啶基吡唑並嘧啶酮及其用途
TWI563001B (en) Disintegrin variants and pharmaceutical uses thereof
IL247325A0 (en) Therapeutic methods using noribogaine and related compounds
GB201406172D0 (en) Therapy and pharmaceutical composition
HK1250926A1 (zh) 抑制劑及其應用
DK3180335T3 (da) Cytokrom-p450-inhibitorer og anvendelser deraf
GB201418809D0 (en) Therapeutic agents and uses thereof
HK1255029A1 (zh) 明膠酶抑制劑及其用途
ZA201808008B (en) Arginase inhibitors and their therapeutic applications
GB201505975D0 (en) Inhibitors and their uses
GB201505971D0 (en) Inhibitors and their uses
GB201410387D0 (en) Compounds and their therapeutic use
GB201416899D0 (en) Medical devices and related methods